Bailey HH et al. |
A phase I trial of perillyl alcohol administered four times daily for 14 days out of 28 days. |
2004 |
Cancer Chemother. Pharmacol. |
pmid:15205914
|
Loutrari H et al. |
Perillyl alcohol is an angiogenesis inhibitor. |
2004 |
J. Pharmacol. Exp. Ther. |
pmid:15210838
|
Gupta A and Myrdal PB |
Development of a perillyl alcohol topical cream formulation. |
2004 |
Int J Pharm |
pmid:14706249
|
Yuri T et al. |
Perillyl alcohol inhibits human breast cancer cell growth in vitro and in vivo. |
2004 |
Breast Cancer Res. Treat. |
pmid:15026623
|
Chen Y and Hu D |
Effects of POH in combination with STI571 on the proliferation and apoptosis of K562 cells. |
2004 |
J. Huazhong Univ. Sci. Technol. Med. Sci. |
pmid:15165112
|
Russell J and Ling CC |
Studies with cytotoxic agents suggest that apoptosis is not a major determinant of clonogenic death in neuroblastoma cells. |
2003 |
Eur. J. Cancer |
pmid:14522384
|
Azzoli CG et al. |
A phase I trial of perillyl alcohol in patients with advanced solid tumors. |
2003 |
Cancer Chemother. Pharmacol. |
pmid:12695855
|
Morgan-Meadows S et al. |
Phase I trial of perillyl alcohol administered four times daily continuously. |
2003 |
Cancer Chemother. Pharmacol. |
pmid:12904896
|
Rajesh D and Howard SP |
Perillyl alcohol mediated radiosensitization via augmentation of the Fas pathway in prostate cancer cells. |
2003 |
Prostate |
pmid:12886519
|
Elegbede JA et al. |
Perillyl alcohol and perillaldehyde induced cell cycle arrest and cell death in BroTo and A549 cells cultured in vitro. |
2003 |
Life Sci. |
pmid:14511768
|